This biotech high-dividend stock is beating S&P 500

Dividend investing can be a profitable strategy for traders, providing an extra source of income alongside potential stock gains. Amgen (NASDAQ: AMGN) has demonstrated strong performance, surpassing the average return of the S&P 500.Since initiating dividend payouts in 2011, AMGN shares have outperformed the S&P 500, with a return of 382.28% compared to the index’s 292.76%.Comparison of returns between AMGN stock and S&P 500. Source: Barchart Earnings ratio and dividend yield make a compelling case for AMGN ...